Orodispersible donepezil

Easai and Pfizer have launched Aricept Evess, an orodispersible tablet containing 5mg or 10mg donepezil hydrochloride.

The orodispersible tablet should be placed on the tongue and given with or without water. Like Aricept film-coated tablets, Aricept Evess is indicated for the symptomatic treatment of mild to moderately severe Alzheimer's dementia. The orodispersible tablets are bioequivalent to the film-coated tablets; the dose recommendations for both formulations are the same.

Further information: Eisai-Pfizer 0208 6001400

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more